Assessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6

NCT ID: NCT01452503

Last Updated: 2023-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

170 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-05-31

Study Completion Date

2008-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of preference for three female condoms (FC).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary goal of this study was to identify the female condom most preferred by study participants. This provided USAID with data to make informed decisions regarding female condom purchases. The study was conducted in three parts. The objective of Part 1 was to familiarize each participant with the three FC types, to minimize learning curve effect in subsequent phases of study, and to gather information on participant demographics, FC acceptability, device function, safety, preference for each of the condom types, and use of male condoms during the same time period. The objective of Part 2 was to determine actual, "unstated" and "unbiased" preference for a particular type of FC. The objective of Part 3 was to identify reasons for preference of a particular FC type and to document details surrounding product use/non-use.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraception

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PATH Women's Condom

PATH Women's Condom

Group Type ACTIVE_COMPARATOR

Path Women's Condom

Intervention Type DEVICE

comparison between 3 types of female condoms

FC2 female condom

Female Health Company's FC2 female condom

Group Type ACTIVE_COMPARATOR

FC2 female condom

Intervention Type DEVICE

comparison between 3 types of female condoms

Reddy 6 female condom (V-Amour)

Reddy 6 female condom (Commercially known as the V-Amour female condom)

Group Type ACTIVE_COMPARATOR

Reddy 6 female condom (V-Amour)

Intervention Type DEVICE

comparison between 3 types of female condoms

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Path Women's Condom

comparison between 3 types of female condoms

Intervention Type DEVICE

FC2 female condom

comparison between 3 types of female condoms

Intervention Type DEVICE

Reddy 6 female condom (V-Amour)

comparison between 3 types of female condoms

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All women enrolled in this research must meet the following selection criteria:

1. must be at least 18 years of age.
2. must be literate (able to read a newspaper or letter easily).
3. must be sexually active (defined as having at least two vaginal coital acts per week and not being abstinent in the month prior to enrollment).
4. must be in an exclusive (monogamous) sexual relationship with her spouse or partner while participating in this research study.
5. must have been in a sexual relationship with this partner for at least 6 months.
6. must be without evidence of STI as determined through syndromic diagnosis and vaginal examination.
7. must be on hormonal or other non-barrier contraception (e.g. OCs, injectables, IUD, or have had a tubal sterilization or be post-menopausal-defined as 12 months with no period).
8. must be willing to give informed consent.
9. must be able to complete condom use log.
10. must be willing to use the study condoms as directed.
11. must be willing to adhere to the follow-up schedule and all study procedures.
12. must have successfully completed a given phase of study before advancing into subsequent phases (e.g. successfully completing Part 1 before advancing to Part 2, etc.).
13. must be willing to provide research study staff with an address, phone number or other locator information while participating in the study.
14. must be willing to participate in the study for up to six months.

Exclusion Criteria

1. must not be a sex worker.
2. must not be pregnant (as determined by pregnancy testing) or planning a pregnancy during the time of the research study.
3. must not be breastfeeding.
4. must not have known sensitivities or allergies to latex, polyurethane, vaginal/sexual lubricants or the lubricants used on condoms.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

United States Agency for International Development (USAID)

FED

Sponsor Role collaborator

University of Witwatersrand, South Africa

OTHER

Sponsor Role collaborator

FHI 360

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mags Beksinska, MSc. PhD

Role: PRINCIPAL_INVESTIGATOR

RHRU

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Commercial City Clinic Department of Health

Durban, , South Africa

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Africa

References

Explore related publications, articles, or registry entries linked to this study.

Beksinska M, Smit J, Joanis C, Hart C. Practice makes perfect: reduction in female condom failures and user problems with short-term experience in a randomized trial. Contraception. 2012 Aug;86(2):127-31. doi: 10.1016/j.contraception.2011.11.071. Epub 2012 Jan 20.

Reference Type DERIVED
PMID: 22264667 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

USAID

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

9928

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exploration of the Neo-Vagina Study
NCT03049371 COMPLETED NA